The symposium is set for Sunday, Sept. 23, 2018 in Philadelphia, Pennsylvania. Up to four prizes of $25,000 each are awarded to the winning presentations and each awardee receives consultation services from the Sheikh Zayed Institute's innovation resource network.
Winners receive financial support and advisory services that help bring pediatric medical devices to market faster by bridging the gap that often follows the prototyping phase in the device development life cycle.
Selected from a field of 45 submissions received from across the U.S. and internationally, the finalists are:
Bardy Diagnostics, Seattle, Washington – a single patient use, continuous recording ambulatory ECG monitor that records for up to 7 days and is useable for all pediatric patients
CardioSounds, Ann Arbor, Michigan – non-invasive blood pressure monitor for continuous and accurate collection of blood pressure data
Circadiance, Pittsburgh, Pennsylvania – next generation cardiorespiratory monitor with Wi-Fi-enabled communication for use in hospital or home care to monitor breathing, heartrate and blood oxygen level in pre-term infants
Design Mentor, Inc., Pelham, New Hampshire – extracorporeal blood pump for short-term cardiopulmonary support of pediatric open-heart surgery patients requiring full or partial cardiopulmonary bypass
Draper, Cambridge, Massachusetts – a pediatric valve designed for children, birth to age 6, that passively expands to a two-fold change in valve diameter to accommodate child growth
EspeRare Foundation, Geneva, Switzerland – a telemetry flow control technology platform for remote adjustment and precise control of pulmonary artery (PA) blood flow and PA blood pressure in congenital heart diseases
Flow Forward Medical, Inc., Fairway, Kansas – Pediatric arteriovenous fistula (AVF) eligibility system to improve hemodialysis treatment using AVF for children with end-stage renal disease
NuPulseCV, Raleigh, North Carolina – a minimally invasive, long-term mechanical circulatory support device for pediatric patients with cardiac dysfunction
PECA Labs, Pittsburgh, Pennsylvania – a novel expandable cardiovascular conduit that uses a minimally-invasive balloon catheter to allow for pediatric growth to reduce surgeries
PolyVascular Corporation, Houston, Texas – a minimally-invasive pediatric pulmonary valve replacement approach for young children with congenital heart disease
PyrAmes, Inc., Cupertino, California – lightweight wireless device to continuously and noninvasively monitor blood pressure of neonates in real time
"There is a profound need for cardiovascular devices made specifically for children, especially the younger subpopulations of children under 18 years of age, where an estimated 1 million children nationally currently live with a congenital heart defect and about 40,000 births annually are affected," said Kolaleh Eskandanian, Ph.D., vice president and chief innovation officer at Children's National and principal investigator of NCC-PDI. "Given the significant need, we decided to focus this year's competition on cardiovascular innovation with the emphasis on also making novel devices available sooner for younger kids. We are grateful to all innovators who applied and are committed to continuing a dialogue with them as well as providing consultation services where we can."
Each finalist will have five minutes to present their innovation to the judging panel, which includes:
Kathryn Zavala, PhD, vice president of operations and business development, MedTech Innovator.
The pitch competition is one feature of the day-long annual symposium devoted to the challenge of bringing more and better medical devices to market to serve the needs of children. Again this year, the nation's leading pediatric innovation symposium is a joint effort with The MedTech Conference powered by AdvaMed. The pediatric symposium brings together medical device innovators, investors, researchers, clinicians and policy makers. This year's theme is "Using Real World Evidence to Drive Pediatric Innovation," recognizing the recently issued finalized guidance from the FDA for medical device developers' use of real world evidence (RWE) and real world data (RWD) to gain FDA approval for medical devices.
Program highlights include a keynote address by Hemant Virkar, president and CEO of Digital Infuzion, Inc. on how real world evidence can shape the regulatory pathway for devices. A live podcast of "BioTalk with Rich Bendis" will feature an interview with Vasum Peiris, M.D., chief medical officer, Pediatrics and Special Populations, FDA , hosted by Richard Bendis, president and CEO of BioHealth Innovation, Inc.
About Children's National Health System Children's National Health System, based in Washington, D.C., has served the nation's children since 1870. Children's National is one of the nation's Top 5 pediatric hospitals and, for a second straight year, is ranked No. 1 in newborn care, as well as ranked in all specialties evaluated by U.S. News & World Report. It has been designated two times as a Magnet® hospital, a designation given to hospitals that demonstrate the highest standards of nursing and patient care delivery. This pediatric academic health system offers expert care through a convenient, community-based primary care network and specialty outpatient centers in the D.C. Metropolitan area, including the Maryland suburbs and Northern Virginia. Home to the Children's Research Institute and the Sheikh Zayed Institute for Pediatric Surgical Innovation, Children's National is the seventh-highest NIH-funded pediatric institution in the nation. Children's National is recognized for its expertise and innovation in pediatric care and as a strong voice for children through advocacy at the local, regional and national levels. For more information, follow us on Facebook and Twitter.